Towards a case definition for devil facial tumour disease: What is it?

EcoHealth

Volumn 4, Issue 3, 2007, Pages 346-351

  Pyecroft, Stephen B ^a   Pearse, Anne Maree ^a   Loh, Richmond ^a   Swift, Kate ^a   Belov, Kathy ^b   Fox, Nolan ^a   Noonan, Erin ^a   Hayes, Dane ^a   Hyatt, Alex ^c   Wang, Lingfa ^c   Boyle, David ^c   Church, Jeff ^c   Middleton, Debra ^c   Moore, Robert ^c  

^a DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CSIRO   (Australia)

Author keywords

Facial tumour; Karyotype; Neoplasm; Neuroendocrine; Sarcophilus harrisii; Tasmanian devil

Indexed keywords

ANIMAL DISEASE; ARTICLE; CHROMOSOME ANALYSIS; DEVIL FACIAL TUMOR DISEASE; DISEASE TRANSMISSION; FACE TUMOR; GENETIC ANALYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

SARCOPHILUS HARRISII;

EID: 35148823198     PISSN: 16129202     EISSN: 16129210     Source Type: Journal    
DOI: 10.1007/s10393-007-0126-0     Document Type: Article

References (19)

1. Barakat M.T., Meeran K., Bloom S.R. (2004) Neuroendocrine tumours, Endocr. Relat. Cancer, 11(1):1-18
2. Bloom F., Paff G., Norback C. R. (1950), "The transmissible venereal tumour of the dog studies indicating that the tumour cells are mature end cells of reticulo-endothelial origin, Am. J. Path. 27:119-140
3. Church J.S., Corino G.L., Woodhead A.L. (1997). Biopolymers, 42:7-17
4. Dingli D., Nowak MA. (2006) Cancer biology: infectious tumour cells. Nature, 443(7107):35-6
5. Fraser R. D. B., MacRae T. P., Miller A. J. (1964). J. Mol. Biol., 10:147-156
6. Gratzinger C. (2004) Tumour biology of gastroenteropancreatic neuroendocrine tumours. Neuroendocrinology, 80(Suppl 1):8-11
7. Griner L.A. (1979) Neoplasms of Tasmanian Devils (Sarcophilus harrisii). J. Nat. Cancer Inst, 62:589-595
8. Hawkins C., Baars C., Hesterman H., Hocking G.J., Jones M.E., Lazenby B., Mann D., Mooney N., Pemberton D., Pyecroft S., Restani M., Wiersma J. (2006) Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrissii. Biol. Conserv. 131:307-324
9. Loh, R., Bergfeld, J., Hayes, D., O'Hara, A., Pyecroft, S., Raidal, S., Sharpe, R. (2006a) The pathology of Devil Facial Tumour Disease (DFTD) in Tasmanian Devils (Sarcophilus harrissii), Vet Pathol 43: 890-895
10. Loh, R., Hayes, D., Mahjoor, A., O'Hara, A., Pyecroft, S., Raidal, S. (2006b) The Immunohistochemical characterisation of Devil Facial Tumour Disease (DFTD) in Tasmanian Devils (Sarcophilus harrissii), Vet Pathol 43: 896-903
11. Lyman, D., Murray-Wijelath, J. (2005). Appl. Spectrosc., 59: 26-32
12. Meuten D.J. (2002) Tumours in Domestic Animals, Iowa State Press, Des Moines, IA, 755-769
13. Murgia C, Pritchard JK, Kim SY, Fassati A, Weiss RA. (2006) Clonal origin and evolution of a transmissible cancer. Cell 126(3):477-87
14. Palacios G, Quan PL, Jabado OJ, Conlan S, Hirschberg DL, Liu Y, Zhai J, Renwick N, Hui J, Hegyi H, Grolla A, Strong JE, Towner JS, Geisbert TW, Jahrling PB, Buchen-Osmond C, Ellerbrok H, Sanchez-Seco MP, Lussier Y, Formenty P, Nichol MS, Feldmann H, Briese T, Lipkin WI. 2007. Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis. 13(1):73-81
15. Pearse A-M, Swift K. 2006 Transmission of devil facial-tumour disease. Nature, 439:549
16. VonHoldt BM, Ostrander EA. (2006) The singular history of a canine transmissible tumor. Cell, 126(3):445-7
17. Wang L.F., Yu M. (2004). Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics. Cur Drug Targets. 5(1):1-15
18. Woodhead, A.L., Harrigan, F.J., Church, J.S. (1997). Assessment of wool chlorination by infrared spectroscopy-II. The chemometric approach. Vib. Spectrosc., 15:179-189
19. York G.K., Steinberg D.A. 2002 The philosophy of Hughlings Jackson. Journal of the Royal Society of Medicine, 96:314-318